Young Trieu
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 24
-
- Protein Degradation and Inhibitors 14
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 3
- Co-authors
- Donna Reece (25 shared papers)Hong Chang (12 shared papers)Suzanne Trudel (15 shared papers)Christine Chen (12 shared papers)Xiaoying Qi (4 shared papers)Wei Xu (5 shared papers)Esther Masih‐Khan (7 shared papers)A. Keith Stewart (3 shared papers)
- Journals
- Blood (12 papers)Clinical Cancer Research (2 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (2 papers)Leukemia Research (2 papers)
- Partner nations
- CanadaUnited StatesNew Zealand
In The Last Decade
Young Trieu
28 papers receiving 713 citations
Peers
Comparison fields: 5 of 56
- Hematology 525
- Oncology 335
- Genetics 93
- Molecular Biology 561
- Pathology and Forensic Medicine 79
Countries citing papers authored by Young Trieu
This map shows the geographic impact of Young Trieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Trieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Trieu more than expected).
Fields of papers citing papers by Young Trieu
This network shows the impact of papers produced by Young Trieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Trieu. The network helps show where Young Trieu may publish in the future.
Co-authors
The 25 scholars most cited alongside Young Trieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 138 | |
| 2 | 2007 | 92 | |
| 3 | 2005 | 68 | |
| 4 | 2006 | 66 | |
| 5 | 2006 | 57 | |
| 6 | 2013 | 47 | |
| 7 | 2004 | 45 | |
| 8 | 2010 | 35 | |
| 9 | 2004 | 33 | |
| 10 | 2009 | 32 | |
| 11 | 2010 | 31 | |
| 12 | 2005 | 24 | |
| 13 | 2007 | 17 | |
| 14 | 2016 | 12 | |
| 15 | 2011 | 8 | |
| 16 | 2012 | 4 | |
| 17 | 2011 | 3 | |
| 18 | 2006 | 3 | |
| 19 | 2009 | 3 | |
| 20 | 2008 | 2 |
About Young Trieu
Young Trieu is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 28 papers that have together received 728 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Protein Degradation and Inhibitors (14 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer therapeutics and mechanisms (3 papers), HIV/AIDS drug development and treatment (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Hematology (525 citations), Oncology (335 citations), Genetics (93 citations), Molecular Biology (561 citations) and Pathology and Forensic Medicine (79 citations). Young Trieu has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Donna Reece, Hong Chang, Suzanne Trudel, Christine Chen, Xiaoying Qi, Wei Xu, Esther Masih‐Khan, A. Keith Stewart, Joseph Mıkhael and Keith Stewart. Their work appears in journals such as Blood, Clinical Cancer Research, British Journal of Haematology, Journal of Clinical Oncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.